Johan Aasbo, DO
Clinical Cardiac Electrophysiology · Lexington, KYNPI 1396820213
Payments from drug & device makers
Across 907 payments — averaging $898.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$663K
- ZOLL Respicardia, Inc.$80K
- Biotronik Inc.$55K
- Abbott$4K
- Impulse Dynamics (USA) Inc.$4K
- Acutus Medical, Inc.$2K
- plus $7K from 25 others
What the payments were for
- Consulting fees$13,8563%
- Speaking & faculty fees$391,16387%
- Travel & lodging$25,5056%
- Food & beverage$20,3805%
- Entertainment$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 488 | $663,351 |
| ZOLL Respicardia, Inc. | 30 | $80,500 |
| Biotronik Inc. | 212 | $55,303 |
| Abbott | 41 | $3,617 |
| Impulse Dynamics (USA) Inc. | 7 | $3,584 |
| Acutus Medical, Inc. | 10 | $2,312 |
| Medtronic(2 entities) | 18 | $1,910 |
| Biosense Webster, Inc. | 11 | $1,669 |
| Atricure, Inc. | 11 | $766 |
| Vektor Medical Inc. | 1 | $500 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $371 |
| Philips North America LLC | 13 | $317 |
| Volta Medical Inc | 2 | $194 |
| Haemonetics Corporation | 1 | $176 |
| Stereotaxis Inc | 2 | $109 |
| Pfizer | 4 | $65 |
| Cardiva Medical, Inc. | 3 | $59 |
| Cordis US CORP. | 2 | $58 |
| Amgen | 3 | $50 |
| Novartis | 3 | $40 |
| Irhythm Technologies, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Novo Nordisk | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 2 | $23 |
| Bayer | 1 | $23 |
| Merck | 1 | $18 |
| Akcea Therapeutics, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$231,516
- EMBLEM MRI S-ICD$62,708
- Rhythmia Mapping System$30,228
- GENERAL - THERAPIES$14,234
- S-ICD System Magnet$9,428
- remede System$9,376
- CLINICAL TRIAL PRODUCT$7,430
- OPTIMIZER$7,081
- WATCHMAN FLX$4,396
- AVEIR$1,908
- Watchman$1,843
- WATCHMAN Access System$1,587
- RHYTHMIA$1,322
- Farapulse$1,273
- Micra$991
- EMBLEM$862
- THERMOCOOL SMARTTOUCH$759
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$500
- vMap$500
- ATRICLIP LAA EXCLUSION SYSTEM$402
How this compares
$815,182 in reported general payments places this provider in the 95th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 430 | $437,802 |
| XareltoRivaroxaban | 106 | $121,752 |
| EntrestoSacubitril/Valsartan | 39 | $32,588 |
| MultaqDronedarone Hcl | 25 | $29,344 |
| Flecainide Acetate | 133 | $10,385 |
| JardianceEmpagliflozin | 14 | $8,450 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $4,195 |
| Dofetilide | 35 | $3,617 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 50 | $2,282 |
| Amiodarone Hcl | 34 | $1,983 |
| Mexiletine Hcl | 13 | $1,847 |
| Metoprolol Succinate | 124 | $1,384 |
| SotalolSotalol Hcl | 77 | $1,341 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $561 |
| ClopidogrelClopidogrel Bisulfate | 74 | $501 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $437,802430 claims |
| Johnson & JohnsonXarelto | $13 | $121,752106 claims |
| NovartisEntresto | $40 | $32,58839 claims |
| Sanofi-aventis U.S. LLCMultaq | $36 | $29,34425 claims |
| Boehringer IngelheimJardiance | $12 | $8,45014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in Lexington
- Gery TomassoniLexington$2.2M
- Joseph SouzaLexington$201K
- John LeeLexington$139K
- Samy ElayiLexington$70K
- David CharlesLexington$32K
- Samuel OmotoyeLexington$32K
- Yousef DarratLexington$29K
- Joel SimonLexington$23K
- Karam AyoubLexington$15K
- Kristin EllisonLexington$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.